A California Christmas 2024 Vyne Therapeutics

A California Christmas 2024 Vyne Therapeutics. Vyne expects to enroll the first patient with. Vyn201 demonstrated positive effect on key biomarkers relevant to vitiligo.

David domzalski discusses how vyne is using this target that is traditionally thought of in oncology in a topical form for vitiligo and an oral therapy for ra and. Common stock (vyne) stock prices, quotes, historical data, news, and insights for informed trading and investment decisions.